Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises OptiGroup in connection with the acquisition of PacksOn in Sweden
Mandate

Vinge advises OptiGroup in connection with the acquisition of PacksOn in Sweden

March 30, 2021 Employment and Benefits Real Estate and Construction Intellectual Property M&A EU, Competition and Regulatory Corporate Crime & Compliance Insurance Law Environmental Law IT, Telecommunications and Outsourcing Banking and Finance Commercial Agreements Carve-Outs

OptiGroup has entered into an agreement to acquire 100% of the shares in PacsOn Sverige AB from Herenco AB. The transaction is subject to the approval of the Swedish Competition Authority.

PacsOn, with a turnover of 840 million SEK in 2020, is a leading provider of products and supply solutions within packaging and business consumables. PacsOn will become part of OptiGroup's Business Area Packaging and will continue to operate under its current brand.

Vinge’s team consisted of partner Christina Kokko together with Johanna Wiberg, Elsie Nassar and Ellen Åkerdahl Flygt (M&A), Nina Gransäter (Banking and Finance), Christoffer Nordin and Alva Hägglund (Commercial Agreements), Ebba Svenburg (Employment), Mathilda Persson (IT), Agnes Perbo (GDPR) Sofia Bergenstråhle (Intellectual Property), Kristoffer Larson (Real Property), Lina Österberg (Environmental law), Victoria Gunnerek (Competition law), Tove Lövgren Frisk (Compliance) and Ellinor Gyllenhammar (VDR).

 

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026